Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia-Reference-Cited by-同舟云学术

Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia

Published:2017-12 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Stieglitz Elliot^ORCID,Mazor Tali,Olshen Adam B.,Geng Huimin,Gelston Laura C.,Akutagawa Jon,Lipka Daniel B.^ORCID,Plass Christoph,Flotho Christian,Chehab Farid F.,Braun Benjamin S.,Costello Joseph F.,Loh Mignon L.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-02178-9.pdf

Reference27 articles.

1. Locatelli, F. et al. Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial. Blood 105, 410–419 (2005).

2. Stieglitz, E. et al. Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children’s Oncology Group. Pediatr. Blood Cancer 62, 629–636 (2015).

3. Dvorak, C. C. & Loh, M. L. Juvenile myelomonocytic leukemia: molecular pathogenesis informs current approaches to therapy and hematopoietic cell transplantation. Front. Pediatr. 2, 25 (2014).

4. Sakaguchi, H. et al. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat. Genet. 45, 937–941 (2013).

5. Stieglitz, E. et al. The genomic landscape of juvenile myelomonocytic leukemia. Nat. Genet. 47, 1326–1333 (2015).

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the classifiers based on mRNA, microRNA and lncRNA expression and DNA methylation profiles for the tumor origin detection;Frontiers in Genetics;2024-06-12

2. Efficacy of the Allosteric MEK Inhibitor Trametinib in Relapsed and Refractory Juvenile Myelomonocytic Leukemia: a Report from the Children’s Oncology Group;Cancer Discovery;2024-06-11

3. In vivo Targeting MEK and TNK2/SRC pathways in PTPN11 driven leukemia;2024-05-18

4. Precision clinical genomics and single subject studies of multi-omics data;Comprehensive Precision Medicine;2024

5. Risk-stratified Treatment for Pediatric Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia;The Hematologist;2024